We are delighted that the Milner Therapeutics Institute has been announced as a finalist for the Award for Innovation in the 2021-2022 Cambridge Independent Science and Technology Awards. Now in their fifth year, these awards showcase a vast range of talent throughout the Cambridge region, from start-up businesses to established Institutions.
Also shortlisted for awards this year are six Milner affiliated companies, bit.bio, Abcam, o2h, Healx, Microbiotica, and Phoremost, and the Milner proudly sits in the same category as our colleagues in the life science and business accelerator Start Codon, which has a base within the Milner Institute.
View the full shortlist here. Winners will be revealed at a ceremony at the Hinxton Hall Conference Centre on the Wellcome Genome Campus on May 11th. Watch this space!
